연구동향 분석

당뇨황반부종에서 유리체강 내 애플리버셉트 주입술 후 할러층두께: 1개월 변화

성수민 이규원 강현구 2022년

논문상세정보
인용/피인용
' 당뇨황반부종에서 유리체강 내 애플리버셉트 주입술 후 할러층두께: 1개월 변화' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Aflibercept
  • Haller layer thickness
  • centralmacularthickness
  • choroidal thickness
  • diabeticmacularedema
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
114 0

0.0%

' 당뇨황반부종에서 유리체강 내 애플리버셉트 주입술 후 할러층두께: 1개월 변화' 의 참고문헌

  • 당뇨황반부종을 대상으로 한 유리체강내 애플리버셉트 치료의 단기 효과
    황재형 [2021]
  • Viewing the choroid : where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema
    Campos A [2017]
  • The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema
    Klein R [1984]
  • Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
    Bahrami B [2017]
  • Retinal-choroidal changes after intravitreal ranibizumab in diabetic macular edema : 12months follow-up
    Giorno P [2014]
  • Relationship between diabetic macular edema and choroidal layer thickness
    Endo H [2020]
  • Light and electron microscopic observations of seven cases
    Hidayat AA [1985]
  • Intravitreal aflibercept for patients with diabetic macular edema refractory to bevacizumab or ranibizumab : analysis of response to aflibercept
    Chen YY [2017]
  • Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema
    Funatsu H [2002]
  • Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists(EURETINA)
  • Five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema(Protocol T Extension Study)
    Glassman AR [2020]
  • Evaluation of the macular choroidal thickness using spectral optical coherence tomography in pseudoexfoliation glaucoma
    Bayhan HA [2016]
  • Enhanced depth imaging spectral-domain optical coherence tomography
    Spaide RF [2008]
  • Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema
    Okamoto M [2018]
  • Effect of intravitreal anti-VEGF on choroidal thickness in patients with diabetic macular edema using spectral domain OCT
  • Effect of focal laser and anti-VEGF therapy on choroidal thickness in diabetic macular edema as measured by enhanced-depth imaging optical coherence tomography
    Manjunath V [2013]
  • Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edema
    Yiu G [2014]
  • Diabetic macular edema with and without subfoveal neuroretinal detachment : two different morphologic and functional entities
    Vujosevic S [2017]
  • Choroidal thickness in diabetic retinopathy : the influence of antiangiogenic therapy
    Laíns I [2014]
  • Choroidal thickness in diabetic patients without diabetic retinopathy : a meta-analysis
    Endo H [2020]
  • Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema
    Campos A [2018]
  • Choroidal changes in diabetic patients with different stages of diabetic retinopathy
    Hamadneh T [2020]
  • Characterisation of choroidal morphological and vascular features in diabetes and diabetic retinopathy
    Gupta P [2017]
  • Changes of choroidal thickness after treatment for diabetic retinopathy
    Lee SH [2014]
  • Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2diabetic patients
    Kim JT [2013]
  • Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity
    Nourinia R [2018]
  • Blood-retinal barrier in hypoxic ischaemic conditions : basic concepts, clinical features and management
    Kaur C [2008]
  • Binding and neutralization of vascular endothelial growth factor(VEGF)and related ligands by VEGF Trap, ranibizumab and bevacizumab
  • Baseline subfoveal choroidal thickness as a predictor for response to short-term intravitreal bevacizumab injections in diabetic macular edema
    Dweikat A [2021]
  • Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion
    Rayess N [2019]
  • Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema
    Rayess N [2015]
  • Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography
    Adhi M [2013]
  • Alterations of choroidal thickness with diabetic neuropathy
    Yazici A [2016]
  • Alteration of layer thickness in the choroid of diabetic patients
    Endo H [2018]
  • Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
    Wells JA [2015]